[Hepatitis B virus. Molecular bases of resistance to new drugs]

Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system.

Journal of medical virology·2004

Multiple sclerosis and human herpesvirus 6.

Infection·2002

ELISA test to detect Chlamydophila pneumoniae IgG.

Journal of basic microbiology·2002

An evaluation of a polyantigenic ELISA to detect Epstein-Barr virus reactivation.

Microbios·2001

HGV RNA sequences in liver and PBMC.

Scandinavian journal of clinical and laboratory investigation·2001

[Chlamydia pneumoniae and cerebrovascular disease].

Revista de neurologia·2001

Advanced neuroimaging in rare diseases: The paradigm of quantification in the era of personalized medicine.

Medicina clinica·2026

Parkinson's disease: Clinical update and new diagnostic and therapeutic approaches.

Medicina clinica·2026

Fabry disease beyond the classical model: clinical presentation and diagnostic challenges in women.

Medicina clinica·2026

Tobacco use and risk of all-cause mortality in individuals with prior myocardial infarction or stroke: A prospective population-based study.

Medicina clinica·2026

Birt-Hogg-Dubé syndrome: From molecular mechanisms to emerging systemic therapeutic strategies.

Medicina clinica·2026

Ultrasound-guided coaxial aspiration for retrieval and repositioning of breast localization markers.

Diagnostic and interventional radiology (Ankara, Turkey)·2026

[Bioengineering solutions for endovascular embolization of abdominal solid organs in trauma].

Khirurgiia·2026

Product and Equipment Coding in National Practitioner Data Bank Malpractice Payment Reports, 2019-2025.

Cureus·2026

Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles.

Molecular therapy. Nucleic acids·2026

Advances in radiolabeled antibody technology: optimization strategies for precision medicine.

International journal of pharmaceutics·2026

Investigation of the pentamidine efficacy against myotonic dystrophy type 1 exploiting polymeric- and lipid-based nanoparticles.

International journal of pharmaceutics·2026

Related Experiment Videos

[Hepatitis B virus. Molecular bases of resistance to new drugs]

Related Concept Videos

Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system.

Multiple sclerosis and human herpesvirus 6.

ELISA test to detect Chlamydophila pneumoniae IgG.

An evaluation of a polyantigenic ELISA to detect Epstein-Barr virus reactivation.

HGV RNA sequences in liver and PBMC.

[Chlamydia pneumoniae and cerebrovascular disease].

Advanced neuroimaging in rare diseases: The paradigm of quantification in the era of personalized medicine.

Parkinson's disease: Clinical update and new diagnostic and therapeutic approaches.

Fabry disease beyond the classical model: clinical presentation and diagnostic challenges in women.

Tobacco use and risk of all-cause mortality in individuals with prior myocardial infarction or stroke: A prospective population-based study.

Birt-Hogg-Dubé syndrome: From molecular mechanisms to emerging systemic therapeutic strategies.

Ultrasound-guided coaxial aspiration for retrieval and repositioning of breast localization markers.

[Bioengineering solutions for endovascular embolization of abdominal solid organs in trauma].

Product and Equipment Coding in National Practitioner Data Bank Malpractice Payment Reports, 2019-2025.

Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles.

Advances in radiolabeled antibody technology: optimization strategies for precision medicine.

Investigation of the pentamidine efficacy against myotonic dystrophy type 1 exploiting polymeric- and lipid-based nanoparticles.

Related Experiment Videos

[Hepatitis B virus. Molecular bases of resistance to new drugs]

Related Concept Videos

Related Articles